Cutland, C. L. Et Al. 2018. Immunogenicity and safety of one or two doses of the quadrivalent meningococcal vaccine MenACWY-TT given alone or with the 13-valent pneumococcal conjugate vaccine in toddlers: A phase III, open-label, randomised study. VACCINE , vol.36, no.14 , 1908-1916.

Cutland, C. L., Nolan, T., Halperin, S. A., Kurugol, Z. A., Ahmed, K., Perrett, K. P., ... Richmond, P.(2018). Immunogenicity and safety of one or two doses of the quadrivalent meningococcal vaccine MenACWY-TT given alone or with the 13-valent pneumococcal conjugate vaccine in toddlers: A phase III, open-label, randomised study. VACCINE , vol.36, no.14, 1908-1916.

Cutland, Clare Et Al. "Immunogenicity and safety of one or two doses of the quadrivalent meningococcal vaccine MenACWY-TT given alone or with the 13-valent pneumococcal conjugate vaccine in toddlers: A phase III, open-label, randomised study," VACCINE , vol.36, no.14, 1908-1916, 2018

Cutland, Clare L. Et Al. "Immunogenicity and safety of one or two doses of the quadrivalent meningococcal vaccine MenACWY-TT given alone or with the 13-valent pneumococcal conjugate vaccine in toddlers: A phase III, open-label, randomised study." VACCINE , vol.36, no.14, pp.1908-1916, 2018

Cutland, C. L. Et Al. (2018) . "Immunogenicity and safety of one or two doses of the quadrivalent meningococcal vaccine MenACWY-TT given alone or with the 13-valent pneumococcal conjugate vaccine in toddlers: A phase III, open-label, randomised study." VACCINE , vol.36, no.14, pp.1908-1916.

@article{article, author={Clare L. Cutland Et Al. }, title={Immunogenicity and safety of one or two doses of the quadrivalent meningococcal vaccine MenACWY-TT given alone or with the 13-valent pneumococcal conjugate vaccine in toddlers: A phase III, open-label, randomised study}, journal={VACCINE}, year=2018, pages={1908-1916} }